Back to top

crispr: Archive

Zacks Equity Research

Vertex (VRTX) Gets Positive CHMP Opinion for Kaftrio Expanded Use

Vertex's (VRTX) Kaftrio gets a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use for extended use to treat younger age groups of two to five years old with cystic fibrosis.

VRTXNegative Net Change ANIKNegative Net Change CRSPPositive Net Change ANVSPositive Net Change